VIDAS TOTAL PSA

FDA Premarket Approval P040008 S011

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

Change to remove extraneous in-process stability tests performed on the strips (str) and on the solid phase receptacles (spr) of the kit, and consequently to add an instruction for the storage of the str during the manufacturing process.

DeviceVIDAS TOTAL PSA
Generic NameTotal, Prostate Specific Antigen (noncomplexed & Complexed) For Detection Of Prostate Cancer
ApplicantBioMerieux, Inc.
Date Received2015-03-18
Decision Date2015-04-22
PMAP040008
SupplementS011
Product CodeMTF 
Advisory CommitteeImmunology
Supplement Type30-day Notice
Supplement ReasonProcess Change - Manufacturer/sterilizer/packager/supplier
Expedited ReviewNo
Combination Product No
Applicant Address bioMerieux, Inc. 595 Anglum Rd. hazelwood, MO 63042

Supplemental Filings

Supplement NumberDateSupplement Type
P040008Original Filing
S013 2016-05-03 30-day Notice
S012 2015-07-06 30-day Notice
S011 2015-03-18 30-day Notice
S010
S009
S008 2014-02-03 30-day Notice
S007 2013-08-15 30-day Notice
S006 2013-02-12 30-day Notice
S005 2013-02-06 30-day Notice
S004 2012-12-18 30-day Notice
S003 2012-10-11 Real-time Process
S002 2012-01-09 30-day Notice
S001 2008-09-04 30-day Notice

NIH GUDID Devices

Device IDPMASupp
03573026156985 P040008 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.